Search by Drug Name or NDC
NDC 24571-0123-02 REGIOCIT 5.03; 5.29 g/1000mL; g/1000mL Details
REGIOCIT 5.03; 5.29 g/1000mL; g/1000mL
REGIOCIT is a EXTRACORPOREAL INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Baxter Healthcare Corporation. The primary component is SODIUM CHLORIDE; SODIUM CITRATE, UNSPECIFIED FORM.
Product Information
| NDC | 24571-0123 |
|---|---|
| Product ID | 24571-123_267ae8b8-32c6-40f8-b977-0d4bd67122b9 |
| Associated GPIs | 99720015002000 |
| GCN Sequence Number | 081039 |
| GCN Sequence Number Description | sodium chloride/sodium citrate SOLUTION 5.03-5.29G MISCELL |
| HIC3 | M9J |
| HIC3 Description | CITRATES AS ANTICOAGULANTS |
| GCN | 48042 |
| HICL Sequence Number | 002996 |
| HICL Sequence Number Description | SODIUM CHLORIDE/SODIUM CITRATE |
| Brand/Generic | Brand |
| Proprietary Name | REGIOCIT |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Sodium Chloride, Sodium Citrate |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION, SOLUTION |
| Route | EXTRACORPOREAL |
| Active Ingredient Strength | 5.03; 5.29 |
| Active Ingredient Units | g/1000mL; g/1000mL |
| Substance Name | SODIUM CHLORIDE; SODIUM CITRATE, UNSPECIFIED FORM |
| Labeler Name | Baxter Healthcare Corporation |
| Pharmaceutical Class | Acidifying Activity [MoA], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE] |
| DEA Schedule | n/a |
| Marketing Category | UNAPPROVED DRUG OTHER |
| Application Number | n/a |
| Listing Certified Through | 2024-12-31 |
Package
NDC 24571-0123-02 (24571012302)
| NDC Package Code | 24571-123-02 |
|---|---|
| Billing NDC | 24571012302 |
| Package | 2 BAG in 1 CARTON (24571-123-02) / 5000 mL in 1 BAG |
| Marketing Start Date | 2020-09-18 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |